Tel: +44 (0)20 7377 0800
Fax: +44 (0)20 7349 5157
Tel: +81 (0)80-1164-4754
Request a Demo
What our customers are saying
When I think of the future, I think of EvaluatePharma
Global pharmaceutical company
EP Vantage Pharma & Biotech Half-Year Review 2015
Pharma & Biotech Half-Year Review 2015 highlights:
- The year started with one of the biggest venture rounds ever with the $450 million Moderna Therapeutics managed to secure from its investors in January.
- VCs gifted $3.8 billion to companies at the half-year point signifying that 2015 could once again raise the bar in terms of funding totals.
- On average, the 32 floats this year yielded only a three percent discount from the listed range, and increased in value by 23% since their IPOs.
Download EP Vantage Pharma & Biotech Half-Year Review 2015